AstraZeneca looses out on European Nexium-related patent decision; downgraded by BarCap


The European Patent Office has invalidated one of the patents - EP1020461 - on Anglo-Swedish drug major…

AstraZenecaBrilintaCardio-vascularCrestorFinancialGastro-intestinalsMarkets & MarketingNexiumPatentsPharmaceuticalTeva Pharmaceutical Industries

District Court rules in favor of Nycomed/Pfizer’s US patent for Protonix


Judge Jose Linares of the US District Court for the District of New Jersey has confirmed the jury verdict…

Gastro-intestinalsGenericsLegalNorth AmericaNycomedPatentsPfizerPharmaceuticalProtonixSchwarz PharmaSun Pharmaceutical IndustriesTeva Pharmaceutical Industries

AstraZeneca grants Teva license to market generic Entocort in USA; Teva’s talampanel fails to meet primary endpoint


Anglo-Swedish drug major AstraZeneca today announced that it has entered into an agreement with the US…

AstraZenecaEntocort ECGastro-intestinalsGenericsLicensingNeurologicalPharmaceuticalResearchtalampanelTeva Pharmaceutical Industries

AstraZeneca settles with Teva over generic Nexium, so avoiding a court battle


Anglo-Swedish drug major AstraZeneca has entered into an agreement with Israel-based generics giant Teva…

AstraZenecaEsomeprazole MagnesiumGastro-intestinalsGenericsLicensingMerck KGaANexiumOmeprazolePatentsPharmaceuticalPrilosecRanbaxy LaboratoriesTeva Pharmaceutical Industries

Back to top